Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Digital Twin Consortium Membership Approaches 150 Companies


https://www.digitaltwinconsortium.org/index.htm

The newly formed Digital Twin Consortium® announced that its membership has grown to nearly 150 in four months since its formation. The Consortium also announced that Autodesk, GE Digital, and Northrop Grumman Corporation are now founding members, joining founders Ansys, Dell Technologies, Lendlease, and Microsoft as well as Executive Director, Dr. Richard Soley and President Bill Hoffman on the Consortium’s Steering Committee.

“Our ecosystem of experts is working feverishly to reduce the risk of implementing digital twin technology – improving interoperability, developing best practices, and influencing requirements for digital twin standards. Today’s announcement shows the importance of digital twin technology to the market; Digital Twin Consortium is the fastest-growing consortium to date,” said Bill Ruh, CEO Lendlease Digital and Chair of the Digital Twin Consortium Steering Committee.

“The value of a digital twin cannot be overstated because of its ability to connect the physical and digital worlds providing real-time operational awareness of structures, machines, or products,” said Nicolas Mangon, Autodesk Vice President for AEC Business Strategy. “As the recognized leader in advanced intelligent 3D modeling, which serves as a foundational component of a digital twin, Autodesk’s participation in the Digital Twin Consortium is motivated by our tradition of openness and working with our peers to advance the industries we serve.”

“With a footprint in 100 countries, GE Digital comprises several software businesses serving the Power Generation, Oil & Gas, Aviation, Electric & Telecommunications Utilities, and the Manufacturing sector,” said Colin Parris, Senior Vice President and Chief Technical Officer for GE Digital and a board member for the Digital Twin Consortium. “The Digital Twins market category is growing quickly. Bodies like the Digital Twin Consortium will play an important role in driving new standards and lowering barriers of entry for industrial companies to accelerate the commercial adoption of digital twins to accelerate business transformation.”

“The consortium will help to better enable cross-industry collaboration while providing a forum to respond to the challenges we all face with digital twin technologies. Creating common standards and practices for digital twins will better enable our ability to deliver products and services more efficiently and more affordably to our customers,” said Silvia Bouchard, corporate director programs, quality, and engineering, Northrop Grumman.

Since its launch on May 18, 2020, the Digital Twin Consortium ecosystem of companies is driving the adoption of digital twins in six core working groups focused on technology and terminology and four industry sectors. Tiger teams are working to accelerate projects like taxonomy types, platform stacks, security and trustworthiness, and the development of uses cases within the key industry sectors of aerospace and defense, infrastructure, natural resources, and manufacturing. Digital Twin Consortium will help enhance the portability and interoperability of digital twins which, in turn, will advance the use of digital twin technology across industries.

“Today, there are no standards, definitions or common language for digital twin technology and therefore it’s been very difficult for companies to integrate it across their product lifecycle and legacy systems,” said Dick Slansky, Senior Analyst, PLM & Engineering Design Tools, ARC Advisory Group. “However, the definition of digital twin is often insufficient to provide a meaningful basis for discussion – especially when comparing digital twin technologies across applications and industries. With so many companies trying to integrate different digital twin technologies, guidance from Digital Twin Consortium comes at a great time.”

Public webinars to demonstrate the priorities for the Digital Twin Consortium begin in September.

Digital Twin Consortium is open to any business, organization, or entity with an interest in digital twins. Its members are committed to using digital twins throughout their operations and supply chains and capturing best practices and standards requirements for themselves and their clients. Membership fees are based on annual revenue.

About Digital Twin Consortium

Digital Twin Consortium is The Authority in Digital Twin. It coalesces industry, government, and academia to drive consistency in vocabulary, architecture, security and interoperability of digital twin technology. It advances the use of digital twin technology in many industries from aerospace to natural resources. Digital Twin Consortium is a program of Object Management Group.

Share article on social media or email:

Enzymedica CEO Scott Sensensbrenner Elected to the American Nutrition Association Strategic Advisory Board to Provide Strategic Vision and Growth Guidance


Scott Sensenbrenner, President & CEO of Enzymedica, has been elected to Board of Directors of the American Nutrition Association.

“Scott brings a valuable new dynamic to the Strategic Advisory Board at the American Nutrition Association with his exceptional depth of experience as a leader and strategist in the natural products industry as well as a long history of heartfelt support of nonprofits,” said ANA CEO Michael Stroka.

Pioneering natural products industry leader and philanthropist Scott Sensenbrenner has been elected to Strategic Advisory Board of the American Nutrition Association® (ANA).

Sensenbrenner has been the driving force behind Enzymedica as President & CEO since 2009, where he expanded the Florida-based natural digestive health brand to be in more than 30,000 retail locations worldwide. Enzymedica is now the number-one selling digestive enzyme company in America. He brings powerful assets to the ANA, particularly in the areas of strategic vision and corporate growth, with leadership experience in the natural products industry spanning more than three decades.

“Scott brings a valuable new dynamic to the Strategic Advisory Board at the American Nutrition Association with his exceptional depth of experience as a leader and strategist in the natural products industry as well as a long history of heartfelt support of nonprofits,” said ANA CEO Michael Stroka, JD, MS, CNS, LDN. “We’re excited to have his expertise on our Board to provide exemplary insight and guidance as we continue to innovate as healthcare leaders to advance our mission to champion the science and practice of personalized nutrition.”

“I’m honored to join the American Nutrition Association Strategic Advisory Board since it is the pinnacle of where my passion lies – helping people gain a personalized approach to good health and nutrition,” said Sensenbrenner. “Good health and nutrition are at the core of who we are at Enzymedica. We search the world to provide consumers with only the highest quality ingredients found in nature which support their optimal health. I’m excited to be a part of this ANA Board since our missions align – we’re making it easier for everyone to have life-changing great health. I’m also looking forward to contributing to expanding the reach of the ANA’s focus on nutrition as a core pillar of healthcare within the medical community.”

In addition to his experience in the natural products industry, Scott is well-known for his philanthropic work. He is a passionate supporter of Mote Marine Laboratory & Aquarium, Safe Place and Rape Crisis Center (SPARCC), Vitamin Angels, and is a Board Member for the Economic Development Corporation for Sarasota County. Previously, he was on the Board of Directors at the Roskamp Institute, a nonprofit focused on pioneering research of diseases of the mind.

About the American Nutrition Association

The American Nutrition Association (ANA) is the professional association for the science and practice of personalized nutrition. A non-profit, the ANA envisions a society of Healthy People, Powered by Nutrition. The ANA Educates, Certifies, Advocates and Connects to fulfill its mission to Champion the Science and Practice of Personalized Nutrition. There are many opportunities to join, invest in, or connect with the ANA. For more information, visit theANA.org.

About Enzymedica

Enzymedica is a Florida-based, natural digestive health company since 1998 that sells to over 30,000 stores worldwide and online. Its top-selling enzyme brand is No. 1 in America. The company has received more than 50 industry awards including multiple Better Nutrition Magazine’s People’s Choice Awards, many Best of Supplements Awards and numerous VITY and Nexty Awards. Visit https://enzymedica.com/ for more information.

Media Contact for Enzymedica

Ria Romano, Partner

RPR Public Relations, Inc.

Tel. 786-290-6413

Share article on social media or email:

Orchid Medical bolsters its physical medicine program with the launch of PT Advance™


News Image

“PT Advance combines clinical oversight and utilization management strategies to provide clients with actionable data to help ensure treatment is effective and positive patient outcomes are achieved.”

Orchid Medical, one of the fastest-growing providers of ancillary medical management solutions in the workers’ compensation industry, today announced the release of PT Advance™ to further strengthen the company’s physical medicine program.

“Orchid Medical is a high-growth organization committed to service excellence in physical therapy management,” said Paul Taylor, president and chief executive officer of Orchid Medical. “PT Advance combines clinical oversight and utilization management strategies to provide clients with actionable data to help ensure treatment is effective and positive patient outcomes are achieved.”

The enhanced program is built on the collection of critical data at key time points during the life of a case and a system-driven, multi-level process to monitor the utilization of each injured employee for evidence-based plans of care and functional recovery. Utilizing case-specific information and proprietary triggers, the company’s technology platform, OMNI®, assigns a PT Advance™ Report Card according to the rehabilitation needs of the injured employee from the start of therapy. Throughout treatment, information is collected in the PT Advance Report Card which provides a real-time clinical assessment of the injured employee’s compliance, progress and potential risks that may impact outcomes. Case managers and claims professionals are provided with this actionable data to help access the effectiveness of treatment.

“We apply an integrated care approach of systematically monitoring the injured employee’s ongoing progress with oversight by a team of clinical experts who provide case-specific coaching,” said Taylor. “Our PT Advance Report Card is key to the success we are seeing within our enhanced physical medicine program.”

The company’s physical medicine program offers referral and care management services performed by physical therapy assistants (PTA), registered nurses and ODG-certified staff as well as nationwide access to credentialed therapists who provide exceptional quality in treating workers’ compensation patients. Orchid Medical’s physical medicine services include physical and occupational therapies, telerehabilitation, speech therapy, aquatic therapy, chiropractic care, certified hand therapy, functional capacity evaluations (FCE), work conditioning and work hardening, and post offer employment testing (POST).

For more information on the company’s physical medicine services and PT Advance™, please email marketing@orchidmedical.com.

About Orchid Medical

Orchid Medical (Orchid) is a leading, nationwide provider of integrated ancillary and surgical implants cost containment solutions for the workers’ compensation industry. Orchid works collaboratively with claims professionals and medical providers to cost-effectively manage and deliver the appropriate care and services injured workers need to recover. The company’s medical management solutions include Surgical Cost Containment Program® (SCCP), DME and supplies, orthotics and prosthetics, home health and complex care, home and vehicle modifications, diagnostic imaging, physical medicine, transportation and language, and urine drug monitoring services. For more information, visit http://www.ORCHIDmedical.com.

# # #

Share article on social media or email:

Butterfly Medical announces encouraging Feasibility Stage data and $7M Series B financing led by New Rhein


Butterfly Medical's non-surgical implant is helping transform treatment for aging men suffering from enlarged prostate (BPH) symptoms.

Butterfly Medical’s non-surgical implant is helping transform treatment for aging men suffering from enlarged prostate (BPH) symptoms.

We don’t believe in a one-size fits all approach to BPH treatment. We believe we’ve developed a simpler, safer device to complement existing therapies and offer a less invasive alternative to patients.

Israeli medical device company, Butterfly Medical Ltd., has raised $7 million in a Series B financing led by Philadelphia-based New Rhein Healthcare Investors. Butterfly Medical successfully completed the enrollment of 49 patient to its multi-center clinical study testing the company’s novel implantable device in patients suffering from benign prostatic hyperplasia (BPH) or an enlarged prostate. Follow up results to date are positive and support initiating a pivotal registration study. The Series B round was raised on the back of encouraging Feasibility Stage (initial safety and efficacy) data. Butterfly Medical will apply the proceeds, $5 million of which was invested by New Rhein funds and $2 million of which was invested by the company’s existing stockholders, to fund its pivotal US clinical trial and open US headquarters.

BPH affects half of all men between the ages of 51 and 60, and up to 90% of men who are 80 or more years old. It occurs when a non-cancerous enlargement of the prostate gland encroaches on the urinary tract, increasing urethral resistance and obstructing the bladder. Symptoms include frequent need to urinate, especially through the night, and pain, among others.

Medications are the first line of treatment for BPH and, while helpful, they can affect male sexual function, may not eliminate symptoms, and frequently lose their benefit over time. Transurethral resection of the prostate (TURP) has been considered by many urologists to be the gold standard of BPH surgical treatment. While efficacious, TURP’s side effects include bleeding, incontinence, and erectile dysfunction. Newer ablative technologies include radiofrequency, laser, and hot steam. However, all these technologies may also result in complications such as pain, bleeding, and/or erectile disfunction.

Given the growing number of older men who live active social lifestyles, the demand for safer procedures is growing. In the US, it is estimated that 12 million men suffering from BPH are delaying treatment, waiting for their symptoms to get worse before undergoing invasive procedures. Butterfly’s device offers a minimally invasive solution: a nitinol implant anatomically shaped, and positioned in the prostatic urethra in order to open the space and relieve BPH symptoms. The device comes in multiple sizes to provide ‘best-fit’ for the individual, and, unlike other more invasive approaches, Butterfly’s procedure does not require any resection, cutting, or burning of prostatic tissue. The procedure can be completed in under six minutes in the urologist’s office.

In clinical trials to date, the Butterfly device showed a lasting effect on quality of life of patients suffering from BPH symptoms: improvement in IPSS (International Prostate Symptoms Score- symptoms severity questionnaire) was observed as early as 2 weeks after the procedure and ranged from 35% at 1 month to 42% improvement for the 17 patients who already completed 12 months.

Idan Geva, CEO of Butterfly Medical, said, “We don’t believe in a one-size fits all approach to BPH treatment. We believe we’ve developed a simpler, safer device to complement existing therapies and offer a less invasive alternative to patients.” Mr. Geva added, “With this financing, and our new partnership with the New Rhein team, we can accelerate our US clinical trials and initiate commercialization in a market eager for simple and safe solutions for this medical condition.”

Initial institutional support and funding for Butterfly was provided by Alon Medtech Ventures, a leading Israeli medical device venture capital firm. New Rhein Managing Partners, Greg Parekh and Ivan Gergel, will join the Butterfly Board of Directors.

Butterfly Board chairman and Alon Medtech founder, Shimon Eckhouse, added: “Butterfly is an excellent example of an entrepreneurial company that has been able to efficiently develop and clinically test an innovative product to address a gap in medical treatment. New Rhein’s complementary support is a positive indication of Butterfly’s results and the size of the market. We look forward to collaborating with New Rhein in advancing the programs and building a successful US business.”

About Butterfly Medical:

Butterfly Medical was founded in late 2014, as part of the portfolio of Alon Medtech Ventures’ incubator, with the goal of developing a non-surgical treatment for men suffering from BPH symptoms. The company was founded by Mr. Yehuda Bachar, a seasoned entrepreneur in the medical device space. The technology developed by the company allows for the procedure to be transferred from the operating room to the clinic, eliminates the need for hospitalization, and significantly shortens recovery time. For more information, see http://www.butterfly-medical.com.

About New Rhein Healthcare Investors:

New Rhein is a venture capital/early growth stage fund manager whose investment strategy focuses on proven molecules used in new ways, such as new delivery forms and potential new uses and indications. In this way, New Rhein limits science-based risk and concentrates on development and execution. Prior investments have included medicines for Alzheimer’s disease, ophthalmic disorders, respiratory disease, and molecular oncology diagnostics. New Rhein’s partners, associates, and advisors are knowledgeable former industry executives with solid track records of operational, investment, and transactional experience. New Rhein combines significant deal-making expertise with deep operating experience, allowing it to tailor the right deal for the right situation and work with its portfolio companies to achieve maximum value for their products. For more information, see http://www.newrhein.com.

Share article on social media or email:

The Trevor Project Releases New Research Report Focused on Black LGBTQ Youth Mental Health


News Image

To improve Black LGBTQ youth mental health and well-being, we need more research, investment, and intersectional solutions that confront systemic barriers head-on.

Today, The Trevor Project, the world’s largest suicide prevention and crisis intervention organization for lesbian, gay, bisexual, transgender, queer & questioning (LGBTQ) young people, released a new research report that examines mental health indicators and suicide risk factors among Black LGBTQ youth, including negative interactions with law enforcement, conversion therapy, housing instability, food insecurity, and barriers to mental health care.

Both LGBTQ youth and Black youth report higher rates of poor mental health due to chronic stress stemming from the marginalized social status they have in U.S. society. The intersection of identities for Black LGBTQ youth make them particularly susceptible to increased victimization and mental health concerns. However, despite the existence of these unique challenges, very little research has quantitatively explored outcomes specific to Black LGBTQ youth. “All Black Lives Matter: The Mental Health of Black LGBTQ Youth” utilizes an intersectional lens to better understand the Black LGBTQ youth experience among a national sample of over 2,500 Black LGBTQ youth by highlighting and building upon many of the findings released from The Trevor Project’s 2020 National Survey on LGBTQ Youth Mental Health as they relate to Black LGBTQ youth.

Key findings include:

-44% of Black LGBTQ youth reported seriously considering suicide in the past 12 months, including 59% of Black transgender and nonbinary youth and half of all Black LGBTQ youth ages 13-17 years old.

-60% of Black LGBTQ youth who wanted mental health care were not able to get it, with more than half citing affordability as the reason they weren’t able to get it.

-Black LGBTQ youth who were involved with police victimization due to their sexual orientation or gender identity reported rates of suicide attempts (32%) that were nearly double that of youth who were not (17%).

-Black LGBTQ youth who had high levels of family support had nearly 3 times lower rates of suicide attempts in the past 12 months. However, less than 1 in 3 Black LGBTQ youth actually reported having high levels of family support.

“Black LGBTQ youth hold multiple marginalized identities, and with that, comes unique stressors and challenges that may make them more susceptible to poor mental health outcomes,” said Myeshia Price-Feeney, Ph.D., a Research Scientist at The Trevor Project. “To improve Black LGBTQ youth mental health and well-being, we need more research, investment, and intersectional solutions that confront systemic barriers head-on. The Trevor Project hopes this report will serve as a call to action for researchers, youth-serving organizations, and policymakers to approach their work through the dual lenses of LGBTQ inclusion and anti-racism.”

The report in its entirety can be found here. Visit TheTrevorProject.org/Resources for resources supporting LGBTQ youth and mental health, including Black and LGBTQ: Approaching Intersectional Conversations and Supporting Black LGBTQ Youth Mental Health.

If you or someone you know is feeling hopeless or suicidal, The Trevor Project’s trained crisis counselors are available 24/7 at 1-866-488-7386, via chat at TheTrevorProject.org/Help, or by texting START

to 678678.

About The Trevor Project

The Trevor Project is the world’s largest suicide prevention and crisis intervention organization for lesbian, gay, bisexual, transgender, queer & questioning (LGBTQ) young people. The Trevor Project offers a suite of 24/7 crisis intervention and suicide prevention programs, including TrevorLifeline, TrevorText, and TrevorChat as well as the world’s largest safe space social networking site for LGBTQ youth, TrevorSpace. Trevor also operates an education program with resources for youth-serving adults and organizations, an advocacy department fighting for pro-LGBTQ legislation and against anti-LGBTQ rhetoric/policy positions, and a research team to discover the most effective means to help young LGBTQ people in crisis and end suicide.

Share article on social media or email:

Abridge Launches to Help People Stay on Top of Their Health


News Image

We built Abridge because we recognized that everyone needs an easy way to remember and understand the details of their care. We can now help so many more people feel comfortable and confident at their medical appointments, and in turn, live healthier lives.

Abridge, the new service helping more people understand the details of their medical care and follow through on doctors’ advice, today announces its official launch. After helping 50,000 people during its pre-launch period, Abridge raised $15M across a Seed and recent Series A, led by Union Square Ventures and healthcare partner UPMC, to continue its effort to bring more compassion and confidence to every step of a person’s healthcare journey.

Developed for individuals seeking care from their doctors, as well as for loved ones who are part of a care team, Abridge gives patients better clarity around their health for more peace of mind. Prior to launching, Abridge surveyed thousands of consumers and found that most (59 percent) said they forgot more than 40 percent of the conversations they had with doctors, specifically the details and important instructions, like what they should do next. Abridge directly addresses this pain point by creating better connections and understanding between people and their doctors.

“It’s no secret that our healthcare system has cracks in it, and while I love my work as a cardiologist, I could only help so many people as a practicing physician. Technology makes it possible to affect the whole system and all the people and doctors impacted,” said Dr. Shiv Rao, co-founder and CEO of Abridge. “We built Abridge because we recognized that everyone needs an easy way to remember and understand the details of their care. We can now help so many more people feel comfortable and confident at their medical appointments, and in turn, live healthier lives.”

How It Works

Powered by machine learning, Abridge provides users with a transcript of the medical parts of the conversations they have with their doctors, highlighting important definitions (the technology has more than 400,000 terms indexed) and takeaways, like next steps or medication instructions. The app can be used for any type of medical appointment, from routine annual exams to urgent care appointments to specialist conversations.

To use the app once it’s downloaded, patients can follow these simple steps:

  • Record a Health Conversation: During a doctor’s appointment, open the Abridge app and simply hit the record button.
  • Decode Medical Jargon: The recording is securely uploaded to a HIPAA-compliant server, and Abridge’s machine learning algorithms create a selective transcript of the medical parts of the conversation. People can use these moments as audio bookmarks that make it easy to skip to the parts that they may want to replay. They can also get definitions to medical terms from trusted sources like the Mayo Clinic.
  • Identify Key Takeaways from the Visit: Abridge identifies and highlights next steps in care, like prescription instructions or follow-up appointments, to help patients stay on top of their health and follow through on their doctor’s advice.

A Team Embedded in Machine Learning

Abridge’s machine-learning foundation is attributed to the deep expertise from a team of Abridge staff led by CTO and Co-founder, Sandeep Konam, Carnegie Mellon University professors, and their respective labs. They’ve worked to bring context and meaning to people’s health through machine learning that deciphers information-dense medical conversations.

Unlike other voice detection services, Abridge’s technology is solving for a more natural setting, grabbing audio signals from a regular conversation, with varying degrees of microphone quality. Abridge’s ability to provide valuable context to medical-jargon-filled conversations–made even more complicated by interruptions, broken utterances, and everything else that happens when people are talking–is a powerful driver for understanding.

“We’re thrilled to support Abridge’s mission to help people better understand and follow through on their health,” said Andy Weissman from Union Square Ventures. “As part of our investment thesis, we back trusted brands like Abridge to broaden access to wellbeing. We believe Abridge can create new trusted relationships between people and their doctors.”

In addition to Union Square Ventures and UPMC, Abridge’s $15 million fundraising to-date includes funding from Bessemer Venture Partners, Pillar, KdT Ventures, and an angel syndicate comprised of Esther Dyson, Aneesh Chopra, and Zen Chu. The new capital will be used to grow the company’s world-class team and continue improving the machine-learning technology and product.

Abridge is available now for iPhone and Android via the App Store and Google Play Store.

###

About Abridge

Abridge helps people stay on top of their health. Whether an appointment takes place in-person or at home via telemedicine, Abridge records the conversation and creates an interactive transcript highlighting the key medical points. By keeping patients, their families, and clinicians on the same page, Abridge brings more understanding and follow-through to every conversation. Visit http://www.abridge.com and @AbridgeHQ to get the latest information.

Share article on social media or email:



DNA BIOPHARM ® Launches Urinary Incontinence Supplement for Females


News Image

In the United States, more than four in 10 women 65 and older have urinary incontinence. With FEMAXEEN®, women can take control of their bladder again without choosing a solution that might otherwise make them feel shameful.

DNA® BIOPHARM (DNA®), today announced the U.S. launch of its female urinary incontinence supplement, FEMAXEEN®, which helps to support a healthy bladder and urinary tract health.

In the United States, more than four in 10 women 65 and older have urinary incontinence. Of approximately 75 million women over the age of 40 (nearly 25 million) suffer from urinary incontinence from mild to severe with many of them choosing adult diapers as their solution. With FEMAXEEN®, women can take control of their bladder again without choosing a solution that might otherwise make them feel shameful.

“As women get older, bladder control and urinary tract health are among their top concerns,” said Oscar del Cid, President and CEO of DNA®. “We want to provide them a less embarrassing solution to their incontinence and that is exactly what FEMAXEEN® does; it gives our customers a safe, tested treatment using natural ingredients to help support a healthy bladder. After all, don’t forget that ‘diapers are for babies’.”

A complete solution for women’s incontinence, FEMAXEEN® has been tested and evaluated through a randomized, double-blind, placebo-controlled study with findings citing a 45.3% reduction in incontinence within two months. The supplement is made with pollen extracts (UriCyTonin®), pumpkin seed extract, and Vitamin E.

Now available in the U.S., FEMAXEEN® can be purchased without a prescription.

To learn more about FEMAXEEN® visit https://femaxeen.com.

About FEMAXEEN®

FEMAXEEN® is distributed by DNA Pharm® as s dietary supplement that helps support lower urinary tract health. A complete solution for women’s incontinence, FEMAXEEN® has been tested and evaluated through a randomized, double-blind, placebo-controlled study with findings citing a 45.3% reduction in incontinence within two months. Now available in the U.S., FEMAXEEN® can be purchased without a prescription.

About DNA BIOPHARM ®

Founded in 1992, DNA® has done business in over 25 countries, covering six continents, and currently operating in America (Miami), Mexico (Mexico City) Europe (Budapest, Hungary), and Africa (Cape Town, South Africa). In 2013, DNA Mexico became one of the largest distributors of The Day After Pill after introducing the pill in 2003 and selling about 30,000,000 units within a 10-year period. Today, DNA® continues to manufacture and distribute a comprehensive line of products that target a wide range of health issues ranging from immune deficiency, psoriasis, acne, adrenal stability, incontinence, and more. DNA® is poised to continue great leaps forward with their tradition of growth, quality, and service worldwide.

Share article on social media or email:

First Patient of the MediSearch Institute Recovering from 20 Years of Pain


Dr. Trent Talbot never gives up until his patients find the help they need.

Dr. Trent Talbot never gives up until his patients find the help they need.

After seventeen years of pain that kept him from working, that nearly kept him from leaving his house, Mallick has now returned to his job as a contractor, and he feels like a new man.

The MediSearch Institute, a new medical practice in Houston, Texas claims they’ve reinvented health care as we know it, and this year, they took on their first patient, Hugh Mallick, to test their case. Now, the results are in.

For almost twenty years, Hugh Mallick had suffered excruciating pain in his neck and across his body and had endured repeated misdiagnoses and failed treatments. Since his initial faulty diagnosis he underwent three neck surgeries which only exacerbated the problem. When the doctors said a fourth neck surgery was in order, Mallick turned to The MediSearch Institute across the country in Houston.

In December, 2019, The MediSearch Institute had opened with a soft launch and started working with several pilot patients. After those patients reported excellent results, MediSearch officially accepted Hugh Mallick as their first full patient in June 2020.

According to founder and visionary Dr. Trent Talbot, most doctors want to help complex patients, but they lack the time and the resources to fully understand them and treat them. Mallick’s doctors never intended to mislead him or subject him to unnecessary surgeries. However, they could not afford the time to read nearly two decades of medical history, and research his case specifically. Instead, they offered the standard treatment for shoulder pain and moved him through the system.

Dr. Talbot says he built MediSearch to be the exact opposite of a typical practice specifically to save complex patients from that fate. Instead of one doctor seeing dozens of patients, Dr. Talbot assigned Mallick to a full team of doctors and medical researchers. Instead of a quick, fifteen minute appointment gathering a single opinion, Mallick’s MediSearch team spent over five hundred “MD Hours” on his case, scouring the world in their research and consulting with fifteen world-renowned experts before presenting their findings to Mallick and his family at their office in Houston.

While Mallick’s other doctors had been focusing on his neck, MediSearch research indicated the pain originated from his right shoulder. Directly following his Houston visit, in August 2020, MediSearch connected Mallick with a respected shoulder surgeon.

After seventeen years of pain that kept him from working, that nearly kept him from leaving his house, Mallick has now returned to his job as a contractor and he feels like a new man. “When I first called MediSearch I didn’t know what to think.” Mallick says, “I hoped they might do something, but I never dreamed they would help me like this. I’m so glad I reached out; that call changed my life, and I am incredibly grateful.”

Celebration for Mallick’s recovery is not limited to his family. Dr. Talbot says: “In the beginning, when MediSearch was just an idea, I dreamed of patients from all over the world flying to Houston to find the best medical advice on the planet. I wanted to give them a level of care never before imagined. Now, I’m ecstatic that my dream is coming to fruition . . . . And this is just the beginning.”

Though Mallick is the first patient to complete the MediSearch process, several other complex patients have begun their own MediSearch journeys. Because MediSearch invests so many resources per client, Dr. Talbot anticipates serving only ten to fifteen patients this next year. That’s why Dr. Talbot created a written guide to help all complex patients navigate the healthcare system. This free report can be found at http://www.MediSearchReport.com.

Dr. Talbot is available for media requests concerning healthcare, medicine, complex and life-threatening conditions, and more. For a full media kit, visit http://www.TrentTalbot.com/press-kit.

Share article on social media or email:

ProductLife Group Acquires Axpharma in Response to Accelerating Global Demand for Pharmacovigilance Support


The merger of PLG and Axpharma offers tremendous potential to further invest in automation and artificial intelligence, as part of our aim to offer reliable, innovative, and cost-effective solutions to our clients that are always one step ahead of what the industry expects

ProductLife Group (PLG), a specialist provider of regulatory and compliance services for the life sciences industry, has today announced the acquisition of pharmacovigilance services provider, Axpharma, in response to a growing focus on safety, quality and speed to market during the continuing pandemic.

The acquisition is in line with PLG’s growth acceleration and transformation plan, supporting the Group’s ambition to be the leading global provider of regulatory and compliance services in life sciences – with offerings spanning regulatory affairs, safety, quality, compliance and pharmacovigilance (PV). PV services, in particular, are currently facing strong and growing international demand from life sciences companies and PLG’s PV capabilities will be strongly bolstered via the Axpharma deal.

Founded in 2001, Axpharma is a prominent pharmacovigilance service provider in Europe. Its team of experts enjoys a strong reputation for providing highly dependable services in the areas of pharmacovigilance responsibility, case management, literature research, medical writing and around-the-clock medical information. Its clients include pharmaceutical, biopharmaceutical medical device and cosmetics companies.

Commenting on the Axpharma acquisition, PLG CEO Xavier Duburcq said, “The merger of PLG and Axpharma offers tremendous potential to further invest in automation and artificial intelligence, as part of our aim to offer reliable, innovative, and cost-effective solutions to our clients that are always one step ahead of what the industry expects. I have known Axpharma for some years and our positive, proactive cultures are a great match.”

For Axpharma, Managing Director Sophie Brisset-Jaillet, said, “We are excited at the prospect of being part of a larger group with an excellent reputation and a broader reach. This is an exciting step for Axpharma, and we are all working hard to ensure a smooth and efficient transition.”

Fabrice Voituron, Managing Partner at 21 Invest, said, “This move embodies the start of a new phase of growth for ProductLife Group. Supported by a new acquisition financing line, the company has the means to support its expansion ambitions and expects to make further announcements in the coming months.”

ProductLife Group has enjoyed robust commercial success in 2020, including some notable COVID-19 safety projects and a significant deal to manage the regulatory and quality activities of a large generic-drug organisation.

About PLG

PLG is a leader in the field of life sciences regulatory compliance outsourcing and consulting services, combining local expertise with global reach in the areas of regulatory affairs, pharmacovigilance and clinical safety, quality and compliance. The Group is structured on a unique business model of technical platforms and geographical hubs, which enables it to offer global support across all therapeutic areas. PLG has a proven -record of successfully managing large global outsourcing programs on behalf of its clients by applying strategic use of smart technology to support clients through the entire product life cycle.

productlifegroup.com

About 21 Invest

21 Invest is a European investment firm, investing in mid-market companies based in Italy, France and Poland, through local funds. The Group has completed more than 105 investments in mid-market over the past 28 years.

21invest.com

PR Contacts

Carina Birt – PR for ProductLife Group

carina@sarumpr.com

+44 7970 006624

Astou Ciss – 21 Invest

a.ciss@21centralepartners.com

+33 (0)1 56 88 33 00

Share article on social media or email:

Celebrity Chef Marc Murphy Appointed as Braintrust Ambassador


News Image

“I struggled as a kid in school because I didn’t have access to the resources that I needed to learn that worked best for me” Chef Marc Murphy

Braintrust, an online marketplace that connects certified educators with families for private tutoring, today announced that celebrity chef and Food Network Judge, Marc Murphy, will join the company as an ambassador and advocate for children with learning disabilities. This role will further solidify his commitment to creating better learning outcomes for children who learn differently, an issue that is especially important during the pandemic.

Chef Murphy is a celebrated Chef & television personality, cookbook author and host of the Food 360 podcast with iHeartRadio. Murphy has navigated his life with dyslexia for as long as he can remember, and now, during Dyslexia Awareness Month, he will officially become a Braintrust ambassador.

In his role at Braintrust, Chef Murphy will focus on advocacy, outreach, fundraising events, and philanthropy, including work with the Braintrust Foundation, a nonprofit arm of Braintrust dedicated to creating better learning opportunities for the 1-in-5 underserved children with a learning disability.

Dyslexia Awareness Month, which occurs from October 1st through October 31st, is a time to come together and raise the profile of this learning challenge, share resources and victories about overcoming language obstacles.

“I struggled as a kid in school because I didn’t have access to the resources that I needed to learn that worked best for me,” says Chef Marc Murphy. “Learning should be explorative and joyful–kids with learning issues need to know they can succeed. Braintrust connects certified educators who are trained in language remediation and that’s why I’m excited to join, so we can make a long-lasting meaningful difference in children’s lives.”

Without having the proper tools or intervention when he was younger Marc learned to deal with dyslexia in his own way throughout his entire education. He has overcome his challenges and gone on to a successful career in the hospitality industry. Chef Murphy made his way through the ranks at several fine dining restaurants in New York City, worked as the Executive Chef in some of the finest kitchens and eventually opened his first solo enterprise, Landmarc Tribeca in 2004 and today is one of New York’s most celebrated chefs.

“Marc shines when talking about dyslexia. You can see his passion for the cause from his personal experiences,” said Jen Mendelsohn, co-founder of Braintrust. “Marc is a true role model because children need to know they are going to get through this, and that with the right support, they will reach their full potential.”

About Braintrust

Braintrust is an online tutoring marketplace where parents can connect with certified teachers and learning specialists for private tutoring and learning interventions for students who learn differently. Our mission is to empower teachers, support families, and create a better tutoring experience. Braintrust is a progressive tutoring company designed by expert teachers and seasoned parents who know there is a better way to help kids capture their spark and discover their love of learning. For more information, visit http://www.braintrusttutors.com and follow @braintrusttutors on Instagram and Facebook.

About Chef Marc Murphy

Marc Murphy is a Chef & Restaurateur who has been cooking for over thirty years. He is a judge on Food Network’s top-rated shows, Chopped and Chopped Junior and has appeared on Guy’s Grocery Games, Guy’s Ranch Kitchen, Beat Bobby Flay, The Today Show, Good Morning America and the Rachael Ray Show among others. Today Murphy’s involvement in the industry moves beyond the kitchen and television. He is both a Food Council & Board Member of City Harvest, New York City’s largest food rescue organization. He also sits on the Leadership Council for Share our Strength’s No Kid Hungry campaign. In 2012, Marc joined the U.S. Department of State’s Diplomatic Culinary Partnership, where he took part in public diplomacy programs, and today he continues that work through the Culinary Diplomacy Project as a Chef Diplomat traveling to destinations around the world as a representative of American culture and cuisine. He is the author of Season with Authority: Confident Home Cooking his top selling cookbook and launched his hosting duties with his debut podcast, Food 360 with Marc Murphy produced by iHeartRadio.

Chef Marc Murphy Contact:

Emily Karpin

emily@benchmarc-restaurants.com

516-319-5083

Share article on social media or email: